• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Authors » Daniel Carlat, MD
Daniel Carlat, MD

Daniel Carlat, MD

Publisher,
Articles
Products
  • Articles
  • Products

ARTICLES

Fact Sheet

Trifluoperazine (Stelazine) Fact Sheet [G] for General Psychiatry

November 19, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Trifluoperazine, like thiothixene (Navane), is an effective older agent with similar potency to haloperidol or fluphenazine; however, given the wide range of antipsychotic options today, it is rarely used.


Read More
Fact Sheet

Pregabalin (Lyrica, Lyrica CR) Fact Sheet [G] for General Psychiatry

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.Full Fact Sheet Editorial Information

Pregabalin is structurally related to gabapentin and is likely more effective for psychiatric disorders, especially generalized anxiety disorder (GAD) and social anxiety disorder. 


Read More
Fact Sheet

Valproic Acid (Depakene, Depakote, others) Fact Sheet [G]

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.Full Fact Sheet Editorial Information

Valproic acid (VPA) is the go-to antimanic agent for acute manic episodes, featuring faster onset of response and a better adverse effect profile compared to lithium, fewer drug interactions than carbamazepine, and efficacy for rapid cycling and relapse prevention.


Read More
Fact Sheet

Oxcarbazepine (Oxtellar XR, Trileptal) Fact Sheet [G] for General Psychiatry

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.Full Fact Sheet Editorial Information

Fact Sheet

Methylphenidate IR (Methylin, Ritalin) Fact Sheet [G] for General Psychiatry

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Methylphenidate has a better side effect profile and somewhat lower abuse potential than amphetamines. However, patients often prefer the “kick” they get from Adderall.


Read More
Fact Sheet

Methamphetamine (Desoxyn) Fact Sheet [G] for General Psychiatry

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Methamphetamine is highly addictive when used in its crystal form (“crystal meth”), because it causes an immediate and intense high when snorted or smoked.


Read More
Fact Sheet

Dextroamphetamine (Dexedrine, Dextrostat, Liquadd, ProCentra, Zenzedi) Fact Sheet [G] for General Psychiatry

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Dextroamphetamine is the D-isomer of racemic amphetamine. 


Read More
Fact Sheet

Clonidine (Catapres, Kapvay) Fact Sheet [G] for General Psychiatry

November 18, 2025
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Clonidine is an alpha-2 agonist with no misuse potential; it does not worsen tics and typically doesn’t cause insomnia.


Read More
psychotherapeutic_options_for_ptsd.jpg
CLINICAL UPDATE

Four Evidence-Based Psychotherapies for PTSD

December 11, 2024
Daniel Carlat, MD
From The Carlat Psychotherapy Report
Issue Links: Editorial Information

Daniel Carlat, MD. Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing. Dr. Carlat has no financial relationships with companies related to this material.

A discussion of four evidence-based therapies for PTSD: prolonged exposure; trauma-focused cognitive behavioral therapy; cognitive processing therapy; and eye movement desensitization and reprocessing.


Read More

Hospital Psychiatry Fact Book, First Edition (2025)

CME Post-Test, Online Access, and Supplemental Materials
November 19, 2024
Victoria Hendrick, MD and Daniel Carlat, MD

This page has links and instructions for taking the 14 CME post-test, download links to supplemental materials, and PDF/eBook access to the Hospital Psychiatry Fact Book (2025).


Read More
View All Articles by Daniel Carlat, MD

PRODUCTS

BULK TAX FREE Treating Opioid Use Disorder—A Fact Book (2024)

Noah Capurso, MD, MHS, Daniel Carlat, MD, and Talia Puzantian, PharmD, BCPP
$54.95
$38.29
$16.66 (30%)

All the tools you need to assess and treat patients struggling with opioid use disorder. 

View
HFB1e_Cover.jpg

Hospital Psychiatry Fact Book, First Edition (2025)

Daniel Carlat, MD and Victoria Hendrick, MD.
No Comments
$97.95

This comprehensive guide is designed to be a valuable resource for professionals working in psychiatric inpatient settings. 

View
OUDFB1e_Cover_Binding.png

Treating Opioid Use Disorder—A Fact Book (2024)

Noah Capurso, MD, MHS, Daniel Carlat, MD, and Talia Puzantian, PharmD, BCPP
$54.95

All the tools you need to assess and treat patients struggling with opioid use disorder. 

View
MFB7e_Print_App_Access.png

Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP
16 Comments
$89.95

The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.

View
MFB7e_PDF_App_Access.png

Medication Fact Book for Psychiatric Practice, Seventh Edition (2024)

Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP
4 Comments
$69.95

The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry, including 10 new fact sheets and 20 patient fact sheets.

View
7--Medication-Fact-Book-for-Psychiatric-Practice,-Sixth-Edition-(2022).png

Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP
No Comments
$69.95

Guidance, clinical pearls, and bottom-line assessments of more than 100 of the most common medications you use and are asked about in your practice. Includes a 12 CME Post-Test.

View
PP1e_epub.png

Prescribing Psychotropics: From Drug Interactions to Pharmacogenetics (2022)

Chris Aiken, MD, Daniel Carlat, MD, and Joshua Feder, MD
2 Comments
$84.95

Teaches drug pharmacokinetics and everyday clinical practice. 

View
8--Prescribing-Psychotropics-From-Drug-Interactions-to-Pharmacogenetics-(2022).png

Prescribing Psychotropics: From Drug Interactions to Pharmacogenetics (2022)

Chris Aiken, MD, Daniel Carlat, MD, and Joshua Feder, MD
No Comments
$64.95

Teaches drug pharmacokinetics and everyday clinical practice.

View
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB8e_SpiralCover.png

    Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

    Updated 2026 prescriber's guide.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2705716055.jpg
    General Psychiatry

    A More Powerful Antidepressant

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.